CIK 0001232524 · Large accelerated filer
Jazz Pharmaceuticals plc
Sign in to watch- Ticker
- JAZZ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- operating
- EIN
- 981032470
- Phone
- 353-1-634-7800
- Business address
- FIFTH FLOOR, WATERLOO EXCHANGE, WATERLOO ROAD, DUBLIN, Ireland, D04 E5W7
- Former names
- JAZZ PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $41,420,682
- in 10 filings, $24.9M under 10b5-1 plans
Net −$41,420,682. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- COZADD BRUCE C −$20.4M Director sold 20% of stake
- Iannone Robert −$19.2M EVP, Global Head of R&D & CMO sold 54% of stake
- GALA RENEE D −$1.2M President & CEO sold 3% of stake
- Carr Patricia −$327K SVP, Chief Accounting Officer sold 18% of stake
- Patil Neena M −$289K EVP & Chief Legal Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-05 | Iannone Robert EVP, Global Head of Research a | Shares withheld for taxes | −2,274 | $142.78 | $325K | 46,489 |
| 2023-03-05 | Carr Patricia SVP, Chief Accounting Officer | Sale | −1,148 | $140.76 | $162K | 7,309 |
| 2023-03-05 | GALA RENEE D EVP & Chief Financial Officer | Shares withheld for taxes | −1,557 | $142.78 | $222K | 43,785 |
| 2023-03-05 | Patil Neena M EVP & Chief Legal Officer | Shares withheld for taxes | −1,923 | $142.78 | $275K | 34,339 |
| 2023-03-05 | Pearce Samantha SVP, Head of Europe & Internat | Shares withheld for taxes | −2,020 | $142.78 | $288K | 13,159 |
| 2023-03-05 | Sablich Kim EVP, GM of U.S., Commercial Ma | Shares withheld for taxes | −1,610 | $142.78 | $230K | 33,573 |
| 2023-03-05 | COZADD BRUCE C Chairman & CEO | Shares withheld for taxes | −21,882 | $142.78 | $3.1M | 387,584 |
| 2023-03-04 | Mulligan Seamus Director | Option exercise | +4,500 | $59.13 | $266K | 1,164,800 |
| 2023-03-04 | Mulligan Seamus Director | Option exercise · Non-Qualified Stock Option (right to buy) | −4,500 | 0 | ||
| 2023-03-03 | Larkin Finbar SVP, Technical Operations | Grant or award | +4,373 | 23,854 | ||
| 2023-03-03 | Swisher Daniel N JR President and COO | Grant or award | +13,456 | 60,440 | ||
| 2023-03-03 | Iannone Robert EVP, Global Head of Research a | Grant or award | +12,447 | 48,763 | ||
| 2023-03-03 | Carr Patricia SVP, Chief Accounting Officer | Grant or award | +2,523 | 8,457 | ||
| 2023-03-03 | GALA RENEE D EVP & Chief Financial Officer | Grant or award | +12,784 | 45,342 | ||
| 2023-03-03 | Patil Neena M EVP & Chief Legal Officer | Grant or award | +9,419 | 36,262 | ||
| 2023-03-03 | Pearce Samantha SVP, Head of Europe & Internat | Grant or award | +3,870 | 15,179 | ||
| 2023-03-03 | Sablich Kim EVP, GM of U.S., Commercial Ma | Grant or award | +10,429 | 35,183 | ||
| 2023-03-03 | COZADD BRUCE C Chairman & CEO | Grant or award | +42,388 | 409,466 | ||
| 2023-02-02 | Pearce Samantha SVP, Head of Europe & Internat | Option exercise | +531 | $109.45 | $58K | 11,840 |
| 2023-02-02 | Pearce Samantha SVP, Head of Europe & Internat | Sale | −531 | $157.26 | $84K | 11,309 |
Page 20 of 31 · 614 trades